
PlenOptika is a technology company dedicated to transforming lives with clear vision through innovative handheld autorefractor and keratometer devices. Their flagship product, QuickSee Free, combines affordable optical components with advanced machine learning and AI technology to deliver clinical-quality eye refraction measurements at a fraction of the cost of traditional equipment. The company targets vision professionals, optical retailers, NGOs, and governments, enabling new care modes that overcome limitations of legacy vision care models. PlenOptika's technology has been used on over 5 million patients in more than 45 countries and has been validated in over 20 clinical studies involving more than 2100 patients. The company collaborates with research institutions and global health organizations and has received multiple international awards and recognition for innovation and impact, including selection for space flight research and prestigious design and innovation awards.

PlenOptika is a technology company dedicated to transforming lives with clear vision through innovative handheld autorefractor and keratometer devices. Their flagship product, QuickSee Free, combines affordable optical components with advanced machine learning and AI technology to deliver clinical-quality eye refraction measurements at a fraction of the cost of traditional equipment. The company targets vision professionals, optical retailers, NGOs, and governments, enabling new care modes that overcome limitations of legacy vision care models. PlenOptika's technology has been used on over 5 million patients in more than 45 countries and has been validated in over 20 clinical studies involving more than 2100 patients. The company collaborates with research institutions and global health organizations and has received multiple international awards and recognition for innovation and impact, including selection for space flight research and prestigious design and innovation awards.